BD Centro Vena Acute Central Line (7 French Dual Lumen)— 510(k) K200266

Substantially Equivalent

Bard Access Systems, Inc. (Bard Has Joined Bd)

FDA 510(k) clearance K200266 for BD Centro Vena Acute Central Line (7 French Dual Lumen), Substantially Equivalent on 2020-04-07. Applicant: Bard Access Systems, Inc. (Bard Has Joined Bd).

Clearance details

Applicant
Bard Access Systems, Inc. (Bard Has Joined Bd)
Product code
Code FOZ
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Salt Lake Ciy,, UT, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code FOZ

product code FOZ
Death
38
Injury
2,290
Malfunction
25,858
Other
11
Total
28,197

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.